Recall archive / FDA drug enforcement

TESTOSTERONE CYPIONATE GS (2 mL) 80 MG/ML Injectable, Packaged in a multi dose 10ML vial, Formula ID 127492, APS Ph... — FDA record D-0735-2022

Reported terminated

Status as reported in the agency record. FDA warns that enforcement status may not track the current recall lifecycle; check the current official notice.

Source date Mar 23, 2022. Retrieved Oct 1, 2026. Last updated Oct 1, 2026.

Archive changed Oct 1, 2026. USDA FSIS records are unavailable; check FSIS directly. Source coverage and dates.

What the record says

Product: TESTOSTERONE CYPIONATE *GS* (2 mL) 80 MG/ML Injectable, Packaged in a multi dose 10ML vial, Formula ID 127492, APS Pharmacy
Reason: Lack of sterility assurance.
Classification: Class II
Recalling firm: Drug Depot, Inc., dba APS Pharmacy
Quantity: 17 vials
Agency-reported status: Terminated
Source record identifier: D-0735-2022

Open the official record

What the recall classes mean. Classification is an agency assessment, not individual medical advice.

Lot and product identifiers

Label field	Details supplied by the agency
Lot, code or applicability	Lot: 746269 BUD: 6/27/2022

Match all identifying details in the current notice. A brand name alone is not enough.

Distribution

Nationwide in the USA including Puerto Rico.

States below are derived from the distribution text, including nationwide wording. They are not inferred from the firm's address.

Dates in the source

Report date: Apr 6, 2022
Recall initiation date: Mar 23, 2022
Center classification date: Mar 29, 2022
Termination date: Oct 5, 2023

FDA company pages use the listing date; enforcement records use initiation dates; CPSC uses recall date; NHTSA uses report-received date. These dates are not interchangeable.